World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 20 September 2021
Main ID:  ISRCTN11154315
Date of registration: 15/05/2018
Prospective Registration: No
Primary sponsor: University of Zurich
Public title: Efficacy of a smoking cessation intervention using smartphones
Scientific title: Efficacy of a randomized controlled trial to promote smoking cessation using mobile applications
Date of first enrolment: 15/04/2018
Target sample size: 240
Recruitment status: Completed
URL:  https://www.isrctn.com/ISRCTN11154315
Study type:  Interventional
Study design:  Single-blind two-arm parallel-group randomized controlled trial with longitudinal design (Treatment)  
Phase:  Not Applicable
Countries of recruitment
Switzerland
Contacts
Name: Philipp    Schwaninger
Address:  University of Zurich Binzmühlestrasse 14 / 14 8050 Zürich Switzerland
Telephone: +41 44 635 72 25
Email: philipp.schwaninger@uzh.ch
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
Adult smoker:
1. 18 years or older
2. Daily smoker (at least one cigarette per day)
3. Intention to quit smoking
4. Own a smartphone with access to mobile internet and daily use
5. Fluent in the German language

Buddies:
1. 18 years or older
2. Current non-smoker (at least 6 months abstinence of tobacco and e-cigarettes)
3. Own a smartphone with access to mobile internet and daily use
4. Fluent in the German language

Exclusion criteria:
Adult smoker:
1. Younger than 18 years old
2. Less than daily smoking
3. 24-hour shift work
4. Simultaneous participation in a professional smoking cessation program or active use of a smoking cessation application
5. Insufficient comprehension of the German language.

Buddies:
1. Current smoker
2. 24-hour shift work
3. Younger than 18 years old
4. Insufficient comprehension of the German language


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Smoking cessation
Mental and Behavioural Disorders
Smoking cessation
Intervention(s)

Participants are randomly allocated to the intervention or control group.
All participants attend a "background assessment" session at the University of Zurich. They are instructed to use a breathalyzer to measure exhaled carbon monoxide, and are instructed to announce a self-quit date.
All participants receive an end of day diary (short questionnaire) which is filled out daily from 7 days before their quit date until 21 days after their quit date, and a breathalyzer to measure carbon monoxide output daily during this period.
Participants are also followed up with a daily diary for three days, six months after their quit date.

Participants in the intervention group are additionally instructed to use the “SmokeFree Buddy app” during 28 consecutive days (7 days prior to the quit date and 21 days afterwards). More information on the “SmokeFree Buddy app”: https://www.smokefree.ch/en/buddy-app/
With the SmokeFree Buddy app participants also have to identify a personal buddy (self-chosen from the personal social network). These buddies get an instruction on how to connect with the target person and to use the “SmokeFree Buddy app“ during the 28 consecutive days to support the smoker in his/her cessation process.

Participants in the control group will have the same setting, but do not receive the mobile intervention “SmokeFree Buddy app” and therefore do not have a supporting buddy.
Primary Outcome(s)

1. Smoking abstinence is measured daily during the 28 day quitting period and for a three day period six months after the quit date, using
1.1. Subjective self reporting (daily diary questionnaires) of abstinence and and number of cigarettes smoked
1.2. Objective exhaled carbon monoxide (in parts per million [ppm]) via Smokerlyzer (iCO Smokerlyzer; Bedfont Scientific Ltd)
Secondary Outcome(s)

1. Intensity and quality of social support is measured daily using self-reporting diary questionnaires throughout the 28 day quitting period and for three days six months after the quit date.
2. Self-efficacy and action control is measured daily using self-reporting diary questionnaires throughout the 28 day quitting period and for three days six months after the quit date.
3. Positive and negative effect is measured daily using self-reporting diary questionnaires throughout the 28 day quitting period and for three days six months after the quit date.
Secondary ID(s)
Nil known
Source(s) of Monetary Support
Universität Zürich
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Ethics Committee of the Faculty of Arts and Social Sciences of the University of Zurich, 13/12/2017, ref: 17.12.13
Results
Results available: Yes
Date Posted:
Date Completed: 20/03/2020
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history